contains a nearly full page article about CRY on
the Science Watch page of the Sunday Reader section.
Main focus is on SynerGraft but also covers BioGlue
and the core business, freezing and preserving
tissue. Here's one quote. "Within days,CryoLofe's newest
product, SynerGraft--a pig's heart valve stripped of its
cells and reseeded with human cells --will be implanted
in a human patient in Australia. If it takes, it
will be the first time a human has has been
successfully treated with a heart valve partially grown in the
lab. If successful, the company might have discovered
a Holy Grail of medicine--a way to provide millions
of parts for patients without needing human donors.
No longer would patients have to depend on the gift
of strangers or use metal or plastic parts. "This
would change everything," Young said. "It would start a
revolution...that would affect literally millions of
Unfortunately the article is not on the AJC web site that I
could see, but it may be worth your while to read it at
your library, or pick up a copy at a major book store
which carries out of town newspapers.
how correct you are. but hindsight is 20/20. at
the time the company had completed a secondary. for
any developing hi-tech this is great more money for
r&d, product dist. etc. guess what? use of proceeds
where shortly announced to be used as insider options
and incentives!!!! thats when all the analysts did a
downgrade and us suckers were stuck in the middle. that is
when i lost total faith. would not trust or touch this
stock ever again!!!!!!!!!!!!!!!!!!!!!
bad advise, sell the dogs and move on. i bought
this puppy at 17 and sold relucantly at 13. this has
been over a year & half ago. my money went to dclk @70
cmgi @ 69 dell @ 36 & aol @ 80. You do the math, I
only buy in 1k lots or larger. why keep the dogs, do
not try to fight the tide BUBBA, face the
of their facility because they think the business
is going to grow. A doubled staff very likely
translates into much more than doubling of revenue. Granted
that this will occur over the next few years but
construction of the facility starts in January. Seems to me
that this is bullish for the long term investor.
If you need the money sell now and either break
even or walk away with a little money in your pocket.
Dont panic. If Bioglue is turned down now, the stock
may drop a bit, but it will eventually go up again.
The future for this company is very positive. Hang in
there, or dont. Do whatever option causes you less
stress,and whichever option will be less painful for your
financial outlook. Going broke hurts a lot more than
getting rich feels good. If you can hang on just
remember, you only lose money on undervalued stocks if you
What are the differences between the bioglue
patch and bioglue products? There aren't any that I
know of. "Patch" is a descriptor for regulatory
purposes that has been used by other companies. Please
correct me if I'm wrong. If the FDA asked them to
withdraw, isn't that a refusal? If it's not a 510K, it has
to be a PMA (an IDE application is part of the PMA
process) which is definitely a multi year process. No more
spin!! You want the truth...You can't handle the truth!!
You stated that CRY's " 510k application was
refused by the FDA" and that "Bioglue will apparently be
evaluated as a PMA." That is ABSOLUTELY NOT TRUE and I have
verified the information with, not only CRY, but the FDA.
First CRY never had a 510k application with the FDA for
Bioglue. They did have a 510k application for the use of
the Bioglue patch for use in pulmonary applications.
The 510k was not refused, as you indicated, the truth
is that the FDA asked them to withdraw the
application and include it as part of their IDE application
for the use of Bioglue in pulmonary applications
which, very frankly, makes sense and that process is not
a multi-year process as you indicated.